Abstract

The goal of this study is to evaluate the prevalence of placenta praevia and the related risks to the mother and unborn child. Assess the significance of early identification and treatment by studying risk variables linked to maternal and foetal morbidity and death in placenta praevia. Methods: This is a Prospective observational study. All pregnant women with placenta praevia admitted in the Dept. of Obstetrics and Gynaecology, GGH, Kakinada, from period of October 2020 to October 2022 with 100 sample size. Results: Majority of study subjects 45% belong to age group of 25-29 years in the present study. 53% were illiterates in the present study, 41% belong to class 4 SES, 42% were zero parity, 48% have one live birth, 58% had no history of abortion. Half of the study subjects had 50% were at term pregnancy. Multiparity is a predominant risk factor in the present study, 84% were cephalic presentation, 39% had type 2 placenta previa, 66% had elective LSCS. Nearly half of the study subjects required 1 unit of blood transfusion, 84% had live births. Half of the study subjects had pre-term babies, 61%, were of low birth weight. Most study subjects 68% had intrapartum hemorrhage as maternal complication. Conclusion: Finally, an efficient referral system, the availability of resources, and public education may all help boost maternal and foetal outcomes. Such precautions will improve the health of the mother and the developing baby in all high-risk pregnancies.

Description